Role of dexmedetomidine infusion after coronary artery bypass grafting.
Tamer HamoudaMohamed IsmailTamer Hamed IbrahimHesham EwilaAhmed Farid ElmahroukPublished in: The cardiothoracic surgeon (2020)
Administration of dexmedetomidine in the early postoperative period can be safe. It may reduce the use of opioids, has sedative, analgesic, and sympatholytic effects that could play a useful role during the management of coronary artery bypass patients, and may improve postoperative recovery.
Keyphrases
- coronary artery bypass grafting
- percutaneous coronary intervention
- coronary artery bypass
- end stage renal disease
- patients undergoing
- ejection fraction
- chronic kidney disease
- newly diagnosed
- low dose
- prognostic factors
- acute coronary syndrome
- spinal cord injury
- atrial fibrillation
- neuropathic pain
- anti inflammatory